Difference between revisions of "Template:Article of the month"

From CannaQAWiki
Jump to navigationJump to search
(Updated for October)
(Updated for November)
Line 1: Line 1:
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig3 Krill Metabolites2020 10-7.png|240px]]</div>
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Tab1 Montoya FrontPharm2020 11.jpg|240px]]</div>
'''"[[Journal:A high-throughput method for the comprehensive analysis of terpenes and terpenoids in medicinal cannabis biomass|A high-throughput method for the comprehensive analysis of terpenes and terpenoids in medicinal cannabis biomass]]"'''
'''"[[Journal:Cannabis contaminants limit pharmacological use of cannabidiol|Cannabis contaminants limit pharmacological use of cannabidiol]]"'''


[[Cannabis]] and its secondary metabolite content have recently seen a surge in research interest. Cannabis [[terpene]]s and [[terpenoid]]s in particular are increasingly the focus of research efforts due to the possibility of their contribution to the overall therapeutic effect of [[Cannabis (drug)|medicinal cannabis]]. Current methodology to quantify terpenes in cannabis biomass mostly relies on large quantities of biomass, long extraction protocols, and long [[gas chromatography]] (GC) gradient times, often exceeding 60 minutes. They are therefore not easily applicable in the high-throughput environment of a cannabis breeding program. The method presented here, however, is based on a simple [[wikipedia:Hexane|hexane]] extract from 40 mg of biomass, with 50 μg/mL [[wikipedia:Dodecane|dodecane]] as internal standard, and a gradient of less than 30 minutes. ('''[[Journal:A high-throughput method for the comprehensive analysis of terpenes and terpenoids in medicinal cannabis biomass|Full article...]]''')<br />
For nearly a century, [[Cannabis|cannabis]] has been stigmatized and [[Legality of cannabis|criminalized]] across the globe, but in recent years, there has been a growing interest in cannabis due to the therapeutic potential of [[Cannabinoid#Phytocannabinoids|phytocannabinoids]]. With this emerging interest in cannabis, concerns have arisen about the possible [[contamination]]s of [[hemp]] with [[pesticide]]s, [[heavy metals]], [[Microorganism|microbial]] pathogens, and [[wikipedia:Carcinogen|carcinogenic]] compounds during the [[Cannabis cultivation|cultivation]], manufacturing, and packaging processes. This is of particular concern for those turning to cannabis for [[Cannabis (drug)|medicinal purposes]], especially those with compromised immune systems. This review aims to provide types of contaminants and examples of cannabis contamination using case studies that elucidate the medical consequences consumers risk when using adulterated cannabis products. ('''[[Journal:Cannabis contaminants limit pharmacological use of cannabidiol|Full article...]]''')<br />
<br />
<br />


''Recently featured'':
''Recently featured'':
: ▪ [[Journal:A high-throughput method for the comprehensive analysis of terpenes and terpenoids in medicinal cannabis biomass|A high-throughput method for the comprehensive analysis of terpenes and terpenoids in medicinal cannabis biomass]]
: ▪ [[Journal:Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis|Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis]]
: ▪ [[Journal:Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis|Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis]]

Revision as of 17:14, 4 November 2020

Tab1 Montoya FrontPharm2020 11.jpg

"Cannabis contaminants limit pharmacological use of cannabidiol"

For nearly a century, cannabis has been stigmatized and criminalized across the globe, but in recent years, there has been a growing interest in cannabis due to the therapeutic potential of phytocannabinoids. With this emerging interest in cannabis, concerns have arisen about the possible contaminations of hemp with pesticides, heavy metals, microbial pathogens, and carcinogenic compounds during the cultivation, manufacturing, and packaging processes. This is of particular concern for those turning to cannabis for medicinal purposes, especially those with compromised immune systems. This review aims to provide types of contaminants and examples of cannabis contamination using case studies that elucidate the medical consequences consumers risk when using adulterated cannabis products. (Full article...)

Recently featured:

A high-throughput method for the comprehensive analysis of terpenes and terpenoids in medicinal cannabis biomass
Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis